Loading data for BAX — first visit, this takes a few seconds.

アラート

Baxter International Inc. (BAX)

NYSE: BAX · リアルタイム株価 · USD

25.94

+0.03 (0.12%)

終値時点： Aug 18, 2026, 8:00 PM

25.86

-0.31%

寄り付き前: 5:00 AM

0.12% (1D)

データがありません

買気配	n/a
時価総額	13.41B
売上高（TTM）	11.47B
純利益（TTM）	-968M
ベータ	0.59
EPS（TTM）	-1.88
PER（TTM）	n/a
予想PER	12.74
PBR（TTM）	2.16
PSR（TTM）	1.17
Earnings Date	Oct 29, 2026

売気配	26.89
出来高	6,671,572
平均出来高（20日）	7,031,929
始値	26.08
前日終値	25.91
当日レンジ	25.75 - 26.34
52週レンジ	15.73 - 30.00
アナリスト	n/a
目標株価	n/a
配当	$0.04 (0.15%)
権利落ち日	2026年8月28日

BAXについて

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant produ...

[続きを読む]

業種 Medical Instruments & Supplies

セクター Healthcare

IPO日 Oct 27, 1981

従業員数 37,500

上場取引所 NYSE

ティッカー BAX

ウェブサイト https://www.baxter.com

企業情報の全文

業績

2025年のBaxter Internationalの売上高は11.24Bで、前年の10.64Bから5.72%の増加でした。利益は-957Mで、47.46%の増加でした。

財務諸表

決算サプライズ

Baxter InternationalはJul 30, 2026に四半期決算を発表しました：

売上高は $2.96B で、予想を下回りました $0, うち 5.34% の前年比増加にあたります.

EPSは 0.56 で、予想を上回りました 0.19, うち -5.08% の前年比減少.

次回決算発表

Baxter International Inc.の決算発表予定日は Oct 29, 2026, 寄り付き前の予定です。
アナリストの売上高予想は ... アップグレード

ニュース

2日前 · StockStory

3 Stocks Under $50 with Questionable Fundamentals

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune t...

4日前 · Zacks

WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?

West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.

5日前 · Zacks

Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.

1週間前 · Simply Wall St.

Does Cardinal Health’s New CAO and Recalls Reveal Shifts in Its Risk Profile and Earnings Quality (CAH)?

In early August 2026, Cardinal Health announced that Anita Zielinski will become Chief Accounting Officer in November, following her interim CFO and senior accounting roles at Baxter and long tenure a...

2週間前 · Simply Wall St.

Baxter (BAX) Stock Gets Fair Value Boost After Q2 Beat And Higher Targets

Baxter International is back in focus after the fair value estimate in one widely used model moved from US$21.54 to US$27.29, a change of about 27% that feeds directly into updated price target discus...

2ページ中1ページ

Baxter International Inc. (BAX)